Protagonist Therapeutics, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK, INC. | 11/12/2025 | 9.40 M | $624.72 M | -2.35% | 14.81% |
| FARALLON CAPITAL MANAGEMENT LLC | 11/14/2025 | 6.20 M | $411.60 M | 0.39% | 9.76% |
| RTW INVESTMENTS, LP | 11/14/2025 | 5.76 M | $382.39 M | 0.00% | 9.06% |
| VANGUARD GROUP INC | 11/07/2025 | 4.26 M | $282.81 M | -2.33% | 6.70% |
| STATE STREET CORP | 11/14/2025 | 3.17 M | $210.30 M | -1.30% | 4.98% |
| BVF INC/IL | 11/14/2025 | 2.56 M | $170.12 M | -20.25% | 4.03% |
| JOHNSON & JOHNSON | 11/13/2025 | 2.45 M | $162.70 M | 0.00% | 3.86% |
| WELLINGTON MANAGEMENT GROUP LLP | 11/14/2025 | 1.91 M | $126.78 M | 83.90% | 3.00% |
| UBS GROUP AG | 11/13/2025 | 1.90 M | $125.95 M | -24.20% | 2.99% |
| DEEP TRACK CAPITAL, LP | 11/14/2025 | 1.72 M | $113.97 M | -47.14% | 2.70% |
| WOODLINE PARTNERS LP | 11/14/2025 | 1.44 M | $95.54 M | 51.89% | 2.26% |
| GEODE CAPITAL MANAGEMENT, LLC | 11/12/2025 | 1.42 M | $94.12 M | -1.91% | 2.23% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 11/14/2025 | 1.22 M | $81.08 M | 30.29% | 1.92% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 11/14/2025 | 1.14 M | $75.72 M | 50.43% | 1.79% |
| JANUS HENDERSON GROUP PLC | 11/14/2025 | 1.10 M | $73.17 M | 146.36% | 1.73% |
| MARSHALL WACE, LLP | 11/13/2025 | 1.09 M | $72.11 M | 100.00% | 1.71% |
| PERCEPTIVE ADVISORS LLC | 11/14/2025 | 1.03 M | $68.43 M | -4.12% | 1.62% |
| COMMODORE CAPITAL LP | 11/14/2025 | 1.03 M | $68.09 M | -4.65% | 1.61% |
| INVESCO LTD. | 11/13/2025 | 1.00 M | $66.68 M | 39.08% | 1.58% |
| ADAR1 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 989.18 K | $65.71 M | 4.34% | 1.56% |
| BANK OF AMERICA CORP /DE/ | 11/14/2025 | 829.88 K | $55.13 M | -2.58% | 1.31% |
| PICTET ASSET MANAGEMENT HOLDING SA | 11/18/2025 | 822.21 K | $54.62 M | 9.34% | 1.29% |
| JEFFERIES FINANCIAL GROUP INC. | 11/13/2025 | 821.50 K | $54.57 M | -0.31% | 1.29% |
| GOLDMAN SACHS GROUP INC | 11/14/2025 | 781.71 K | $51.93 M | 0.57% | 1.23% |
| MORGAN STANLEY | 11/14/2025 | 768.36 K | $51.04 M | -11.58% | 1.21% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 11/14/2025 | 718.20 K | $47.71 M | -34.25% | 1.13% |
| LYNX1 CAPITAL MANAGEMENT LP | 11/13/2025 | 700.01 K | $46.50 M | -4.50% | 1.10% |
| NORTHERN TRUST CORP | 11/14/2025 | 603.22 K | $40.07 M | -1.93% | 0.95% |
| AMERICAN CENTURY COMPANIES INC | 11/12/2025 | 600.05 K | $39.86 M | -26.28% | 0.94% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 11/10/2025 | 552.88 K | $36.73 M | -3.91% | 0.87% |
| FMR LLC | 11/13/2025 | 520.66 K | $34.59 M | -3.30% | 0.82% |
| MANGROVE PARTNERS | 11/14/2025 | 478.41 K | $31.78 M | 21.00% | 0.75% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 11/07/2025 | 451.77 K | $30.01 M | 1.29% | 0.71% |
| COLONY GROUP, LLC | 11/14/2025 | 448.99 K | $29.83 M | 100.00% | 0.71% |
| TORONTO DOMINION BANK | 11/14/2025 | 445.44 K | $29.59 M | 0.00% | 0.70% |
| DIMENSIONAL FUND ADVISORS LP | 11/12/2025 | 438.52 K | $29.13 M | 143.55% | 0.69% |
| 683 CAPITAL MANAGEMENT, LLC | 11/14/2025 | 407.50 K | $27.07 M | -8.43% | 0.64% |
| BANK OF NEW YORK MELLON CORP | 11/03/2025 | 363.26 K | $24.13 M | -6.40% | 0.57% |
| PRINCIPAL FINANCIAL GROUP INC | 11/04/2025 | 326.09 K | $21.66 M | -1.23% | 0.51% |
| VOYA INVESTMENT MANAGEMENT LLC | 10/09/2025 | 305.42 K | $20.29 M | 8.94% | 0.48% |
| LOGOS GLOBAL MANAGEMENT LP | 11/14/2025 | 300.00 K | $19.93 M | 100.00% | 0.47% |
| RAYMOND JAMES FINANCIAL INC | 11/14/2025 | 294.30 K | $19.55 M | -5.67% | 0.46% |
| ALLIANCEBERNSTEIN L.P. | 11/14/2025 | 260.85 K | $17.33 M | 284.17% | 0.41% |
| JPMORGAN CHASE & CO | 11/26/2025 | 252.40 K | $16.77 M | -43.37% | 0.40% |
| CITADEL ADVISORS LLC | 11/14/2025 | 237.88 K | $15.80 M | 774.53% | 0.37% |
| PUBLIC SECTOR PENSION INVESTMENT BOARD | 11/06/2025 | 228.15 K | $15.16 M | 7.98% | 0.36% |
| AFFINITY ASSET ADVISORS, LLC | 11/13/2025 | 220.60 K | $14.65 M | -49.86% | 0.35% |
| KENNEDY CAPITAL MANAGEMENT LLC | 11/13/2025 | 208.44 K | $13.85 M | 54.52% | 0.33% |
| BARCLAYS PLC | 11/12/2025 | 171.41 K | $11.39 M | -19.19% | 0.27% |
| RHUMBLINE ADVISERS | 11/06/2025 | 163.98 K | $10.89 M | -5.23% | 0.26% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Protagonist Therapeutics, Inc. institutional Ownership - FAQ's
During the previous two years, 353 institutional investors and hedge funds held shares of Protagonist Therapeutics, Inc.. The most heavily invested institutionals were:
BlackRock, Inc.: 9.4 M
FARALLON CAPITAL MANAGEMENT LLC: 6.2 M
RTW INVESTMENTS, LP: 5.76 M
VANGUARD GROUP INC: 4.26 M
STATE STREET CORP: 3.17 M
BVF INC/IL: 2.56 M
111.29% of Protagonist Therapeutics, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 82.00 M shares in the last 24 months. This purchase volume represents approximately $5.32 B in transactions.